181 related articles for article (PubMed ID: 35898882)
1. The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer.
Wang J; Lin W; Li R; Cheng H; Sun S; Shao F; Yang Y; Zhang L; Feng X; Gao S; Gao Y; He J
Front Oncol; 2022; 12():899987. PubMed ID: 35898882
[No Abstract] [Full Text] [Related]
2. A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability.
Wang J; Shao F; Yang Y; Wang W; Yang X; Li R; Cheng H; Sun S; Feng X; Gao Y; He J; Lu Z
Cancer Commun (Lond); 2022 Oct; 42(10):1008-1027. PubMed ID: 35975322
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide inhibits the growth of cancer stem cells derived from small cell lung cancer by downregulating stem cell-maintenance factors and inducing apoptosis via the Hedgehog signaling blockade.
Chang KJ; Yin JZ; Huang H; Li B; Yang MH
Transl Lung Cancer Res; 2020 Aug; 9(4):1379-1396. PubMed ID: 32953511
[TBL] [Abstract][Full Text] [Related]
4. IL-8 regulates the stemness properties of cancer stem cells in the small-cell lung cancer cell line H446.
Jin F; Miao Y; Xu P; Qiu X
Onco Targets Ther; 2018; 11():5723-5731. PubMed ID: 30254465
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression.
Ventura R; Mordec K; Waszczuk J; Wang Z; Lai J; Fridlib M; Buckley D; Kemble G; Heuer TS
EBioMedicine; 2015 Aug; 2(8):808-24. PubMed ID: 26425687
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and B-Cell Growth Transformation Induce Lipogenesis through Fatty Acid Synthase.
Hulse M; Johnson SM; Boyle S; Caruso LB; Tempera I
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208446
[TBL] [Abstract][Full Text] [Related]
7. Targeting the SREBP-1/Hsa-Mir-497/SCAP/FASN Oncometabolic Axis Inhibits the Cancer Stem-like and Chemoresistant Phenotype of Non-Small Cell Lung Carcinoma Cells.
Tiong TY; Weng PW; Wang CH; Setiawan SA; Yadav VK; Pikatan NW; Fong IH; Yeh CT; Hsu CH; Kuo KT
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806291
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinase USP13 promotes the epithelial-mesenchymal transition and metastasis in gastric cancer by maintaining Snail protein.
Zhang T; Zheng J; Qiao L; Zhao W
Pathol Res Pract; 2022 Jan; 229():153705. PubMed ID: 34872023
[TBL] [Abstract][Full Text] [Related]
9. The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer.
Morgan EL; Patterson MR; Barba-Moreno D; Scarth JA; Wilson A; Macdonald A
Oncogene; 2021 Mar; 40(11):2112-2129. PubMed ID: 33627786
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis.
Tao T; Su Q; Xu S; Deng J; Zhou S; Zhuang Y; Huang Y; He C; He S; Peng M; Hocher B; Yang X
J Cell Physiol; 2019 Mar; 234(3):3088-3104. PubMed ID: 30221356
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer.
Zaytseva YY; Rychahou PG; Le AT; Scott TL; Flight RM; Kim JT; Harris J; Liu J; Wang C; Morris AJ; Sivakumaran TA; Fan T; Moseley H; Gao T; Lee EY; Weiss HL; Heuer TS; Kemble G; Evers M
Oncotarget; 2018 May; 9(37):24787-24800. PubMed ID: 29872506
[TBL] [Abstract][Full Text] [Related]
12. USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer.
Man X; Piao C; Lin X; Kong C; Cui X; Jiang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):259. PubMed ID: 31200745
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-Inducible Ubiquitin Specific Peptidase 13 Contributes to Tumor Growth and Metastasis via Enhancing the Toll-Like Receptor 4/Myeloid Differentiation Primary Response Gene 88/Nuclear Factor-κB Pathway in Hepatocellular Carcinoma.
Gao S; Chen T; Li L; Liu X; Liu Y; Zhao J; Lu Q; Zeng Z; Xu Q; Huang D; Tu K
Front Cell Dev Biol; 2020; 8():587389. PubMed ID: 33195243
[TBL] [Abstract][Full Text] [Related]
14. Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.
Li L; Che L; Tharp KM; Park HM; Pilo MG; Cao D; Cigliano A; Latte G; Xu Z; Ribback S; Dombrowski F; Evert M; Gores GJ; Stahl A; Calvisi DF; Chen X
Hepatology; 2016 Jun; 63(6):1900-13. PubMed ID: 26910791
[TBL] [Abstract][Full Text] [Related]
15. USP13 serves as a tumor suppressor via the PTEN/AKT pathway in oral squamous cell carcinoma.
Qu Z; Zhang R; Su M; Liu W
Cancer Manag Res; 2019; 11():9175-9183. PubMed ID: 31802942
[TBL] [Abstract][Full Text] [Related]
16. The cancer stemness inhibitor napabucasin suppresses small cell lung cancer growth through SOX2 expression.
Li JM; Hsu PC; Kuan FC; Shi CS; Yang CT
Am J Cancer Res; 2022; 12(10):4637-4651. PubMed ID: 36381330
[TBL] [Abstract][Full Text] [Related]
17. Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis.
Han Z; Liu M; Xie Y; Zeng K; Zhan Z; Chen Y; Wang L; Chen X; Luo Y; Zeng Y; Zhan H; Lin Y; Zhang K; Zhu X; Liu S; Luo X; Zhou A
Cell Death Discov; 2022 Nov; 8(1):445. PubMed ID: 36333288
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors.
Zhang S; Zhang M; Jing Y; Yin X; Ma P; Zhang Z; Wang X; Di W; Zhuang G
Nat Commun; 2018 Jan; 9(1):215. PubMed ID: 29335437
[TBL] [Abstract][Full Text] [Related]
19. Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination.
Fang X; Zhou W; Wu Q; Huang Z; Shi Y; Yang K; Chen C; Xie Q; Mack SC; Wang X; Carcaboso AM; Sloan AE; Ouyang G; McLendon RE; Bian XW; Rich JN; Bao S
J Exp Med; 2017 Jan; 214(1):245-267. PubMed ID: 27923907
[TBL] [Abstract][Full Text] [Related]
20. Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth.
Lin HP; Cheng ZL; He RY; Song L; Tian MX; Zhou LS; Groh BS; Liu WR; Ji MB; Ding C; Shi YH; Guan KL; Ye D; Xiong Y
Cancer Res; 2016 Dec; 76(23):6924-6936. PubMed ID: 27758890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
